In last trading session, Surgery Partners Inc (NASDAQ:SGRY) saw 0.88 million shares changing hands with its beta currently measuring 2.60. Company’s recent per share price level of $22.58 trading at -$0.83 or -3.55% at ring of the bell on the day assigns it a market valuation of $2.87B. That closing price of SGRY’s stock is at a discount of -63.51% from its 52-week high price of $36.92 and is indicating a premium of 5.4% from its 52-week low price of $21.36. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.67 million shares which gives us an average trading volume of 894.05K if we extend that period to 3-months.
For Surgery Partners Inc (SGRY), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.55. Splitting up the data highlights that, out of 8 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Surgery Partners Inc (NASDAQ:SGRY) trade information
Upright in the red during last session for losing -3.55%, in the last five days SGRY remained trading in the red while hitting it’s week-highest on Friday, 11/29/24 when the stock touched $22.58 price level, adding 6.31% to its value on the day. Surgery Partners Inc’s shares saw a change of -29.42% in year-to-date performance and have moved -3.30% in past 5-day. Surgery Partners Inc (NASDAQ:SGRY) showed a performance of -23.22% in past 30-days. Number of shares sold short was 10.07 million shares which calculate 10.96 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 38 to the stock, which implies a rise of 40.58% to its current value. Analysts have been projecting 31 as a low price target for the stock while placing it at a high target of 64. It follows that stock’s current price would drop -37.29% in reaching the projected high whereas dropping to the targeted low would mean a loss of -37.29% for stock’s current value.
Surgery Partners Inc (SGRY) estimates and forecasts
Statistics highlight that Surgery Partners Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -18.19% of value to its shares in past 6 months, showing an annual growth rate of -4.00% while that of industry is 5.10. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 54.69% during past 5 years. In 2024, company’s earnings growth rate is likely to be around -13.75% while estimates for its earnings growth in next 5 years are of 46.10%.
Surgery Partners Inc (NASDAQ:SGRY)’s Major holders
Insiders are in possession of 1.12% of company’s total shares while institution are holding 110.02 percent of that, with stock having share float percentage of 111.26%. Investors also watch the number of corporate investors in a company very closely, which is 110.02% institutions for Surgery Partners Inc that are currently holding shares of the company. BAIN CAPITAL INVESTORS LLC is the top institutional holder at SGRY for having 49.95 million shares of worth $1.19 billion. And as of 2024-06-30, it was holding 39.6493 of the company’s outstanding shares.
The second largest institutional holder is FMR LLC, which was holding about 17.76 million shares on 2024-06-30. The number of shares represents firm’s hold over 14.1023 of outstanding shares, having a total worth of $422.63 million.
On the other hand, Janus Henderson Contrarian Fund and Fidelity Select Portfolios – Health Care are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 5.04 shares of worth $120.16 million or 3.97% of the total outstanding shares. The later fund manager was in possession of 3.75 shares on Sep 30, 2024 , making its stake of worth around $89.4 million in the company or a holder of 2.95% of company’s stock.
